Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Regenerex Pharma's operating assets for the quarter that ended in Sep. 2025 was $0.61 Mil. Regenerex Pharma's operating liabilities for the quarter that ended in Sep. 2025 was $1.18 Mil. Regenerex Pharma's Total Assets for the quarter that ended in Jun. 2025 was $0.76 Mil. Therefore, Regenerex Pharma's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2025 was -0.75.
Regenerex Pharma Scaled Net Operating Assets Related Terms
Regenerex Pharma Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Regenerex Pharma's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regenerex Pharma Scaled Net Operating Assets Chart
RGPX vs CABN, TEKXD, DLYT: Scaled Net Operating Assets Comparison
For the Medical Instruments & Supplies subindustry, Regenerex Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regenerex Pharma Scaled Net Operating Assets vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Regenerex Pharma's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of -0.75 mean?
Regenerex Pharma (RGPX) has a Scaled Net Operating Assets of -0.75 as of Sep. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Regenerex Pharma and its competitors.
Is Regenerex Pharma's Scaled Net Operating Assets too high?
Regenerex Pharma's current Scaled Net Operating Assets is -0.75.
How does Regenerex Pharma's Scaled Net Operating Assets compare to CABN and TEKXD?
Regenerex Pharma's Scaled Net Operating Assets of -0.75 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Regenerex Pharma and its competitors. Regenerex Pharma's current Scaled Net Operating Assets is -0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerex Pharma stock overvalued right now?
Regenerex Pharma (RGPX) has a current Scaled Net Operating Assets of -0.75. The current Scaled Net Operating Assets is -0.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Regenerex Pharma (RGPX), the current Scaled Net Operating Assets is -0.75 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Regenerex Pharma Inc develops and markets Woundcare Healing products. The current product technology provides the company with a number of complete wound care protocols to treat all wounds, such as diabetic ulcers, pressure ulcers, burns, and surgical wounds. Its product Xcellderma OTC a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds; Accelerex Sterile Wound Cream is for the treatment of a wide variety of chronic and acute wounds; and Accelerex Impregnated Sterile Wound Dressing use as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGPX has been successfully added to your 
